#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Drug eruption Renal cell carcinoma Arterial tortuosity syndrome Colitis ulcerative Precursor T-lymphoblastic lymphoma/leukaemia recurrent Langerhans' cell histiocytosis Von Willebrand's disease Gastroenteropancreatic neuroendocrine tumour disease Peritoneal mesothelioma malignant Primary biliary cholangitis Pulmonary sarcoidosis Cutaneous T-cell lymphoma recurrent Laryngeal squamous cell carcinoma Encephalopathy neonatal Pulmonary alveolar haemorrhage More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome Netherton’s syndrome – Treatment Paraneoplastic neurological syndrome – Treatment Richter’s syndrome – Treatment Skin angiosarcoma Nephrotic syndrome – Treatment Familial amyotrophic lateral sclerosis – Treatment Cystic fibrosis lung – Life with Disease Hypereosinophilic syndrome – Treatment Chronic granulomatous disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Oxitriptan Iph5201 Prasterone Elotuzumab LINAPRAZAN GLURATE Other Immunosuppressants Meropenem Trihydrate Cabazitaxel INSULIN DETEMIR Cobamamide Calcium Folinate Pentahydrate Interleukin-2 ALG-000184 Festuca Elatior Pollen Extract Levocabastine Hydrochloride Benserazide Hydrochloride Betamethasone Dipropionate Tenofovir Disoproxil Adrenaline Acid Tartrate Bp More therapies…

    Learn about Your Condition

    Alport's syndrome Organ donor Embolic stroke Henoch-Schonlein purpura Tricuspid valve disease Cardiogenic shock Psoriasis Malignant lymphoid neoplasm Follicular lymphoma stage II Angiosarcoma Death neonatal Chondroplasty Sinus rhythm Breast cancer stage I Iron deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer metastatic

  • Study Comparing Ivonescimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Ivonescimab
    • Carboplatin
    • Paclitaxel
    Belgium France Germany Greece Ireland Italy +3

  • Study Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium Denmark Finland France Germany +7

  • Study on the Effectiveness and Safety of Lazertinib and Gefitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Lung adenocarcinoma stage III
    • Lung adenocarcinoma stage IV
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Gefitinib
    • Lazertinib
    Greece Hungary

  • Study Comparing the Effects and Safety of FYB206 and Pembrolizumab with Chemotherapy in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Pembrolizumab
    Bulgaria Poland Romania

  • Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Inupadenant Hydrochloride
    Belgium Czechia France Germany Italy Spain

  • Study of CLN-081 tablets in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations who have previously received platinum chemotherapy

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer recurrent
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Cln-081
    Italy The Netherlands Spain
Previous Page
1 … 7 8 9 10 11 … 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!